Skip to content

Mission Reconnect-Veterans and Their Partners to Manage Pain and PTSD (MR)

CompletedNot applicableNCT03593772
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

This project is responsive to Rehabilitation Research and Development's (RR\&D) current special areas of interest for non-pharmacological activity-based interventions for chronic pain impacting pain reduction, function and quality of life. This project aligns with the VA mandate for complementary and integrative health (CIH) care for Veterans and their families. CIH complements traditional care for Veterans managing chronic conditions, such as chronic pain and PTSD. Mission Reconnect (MR) is a user-driven, dyadic, CIH self-care management program delivered remotely that teaches techniques the Veteran/partner dyad can use to reduce pain, anxiety and stress, promote well-being and improve relationship quality. The research goal is to evaluate MR as an approach to manage chronic pain and PTSD symptoms, for potential subsequent implementation. This study will possibly provide a model for establishing remote access and sustainable implementation of CIH within VA.

Study details

Official title
Mission Reconnect: Delivering a Mobile and Web Based Self Directed Complementary and Integrative Health Program to Veterans and Their Partners to Manage Pain and PTSD
Interventions
  • Behavioral: Mission Reconnect
Sponsor
VA Office of Research and Development
Start date
2019-10-08
Primary completion
2022-07-18
Sex
All
Age range
from 18 Years
Healthy volunteers
true
Results posted
Yes, on ClinicalTrials.gov
Countries
United States
Total sites listed
3

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * English-speaking Veterans with chronic musculoskeletal pain. * Veteran is considered to have chronic musculoskeletal pain if he or she meeting either of two validated criteria: * (1) Having 2+ occurrences of any of targeted musculoskeletal ICD-9-CM codes "likely to represent chronic pain" recorded at visits separated by at least 30 days within past six months * (2) Having high impact chronic pain = 2+ occurrences of targeted musculoskeletal ICD-9-CM codes separated by at least 30 days within the past six months previous to study recruitment and two or more pain scores greater than or equal to 4 separated by at least 30 days within past six months. * For pain scores, the investigators will use the 0-10 numeric pain rating scale that is routinely collected at the VA. * The investigators will count two ICD-9-CM codes or pain scores recorded on the same day as one code/score. * Veteran is considered to have PTSD if he or she has a flag in his/her record indicating confirmed condition by the VA Compensation and Benefits program, has at least two outpatient visits in the year with the primary diagnosis being listed as PTSD (ICD-9-CM code 309.81) and/or had PTSD listed on the problem list\], Veteran must also have PTSD (defined by PTSD diagnosis-ICD-9-CM 309.81), the ability to access and use an electronic platform (e.g. Mobile device, internet, DVD) for MR delivery, with a willing partner to also participate in the study and MR program. Exclusion Criteria: * Moderate to severe traumatic brain injury (TBI) * Diagnosis or documented treatment for psychosis in previous 6 months * Currently in substance use disorder treatment * Non-English speaking * Visual, hearing, cognitive impairment that prevent participation or ability to consent * And/or lack of access to internet service * These individuals will be excluded due to medical, language, and technology access issues that would prevent safe and full study participation. * Pain and PTSD treatment will not be factored as an inclusion/exclusion criteria but will be evaluated as covariates. * Potential participants who screen for aggression or violence will also be excluded from study.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03593772